DNA Methylation and Developmental Genes in Lymphomagenesis—More Questions Than Answers?

References

• Holliday R., Pugh J. E. DNA modification mechanisms and gene activity during development. Science 1975; 187: 226–232
   PubMed Web of Science ®Google Scholar
• Monk M. Methylation and the X‐chromosome. Bioessays 1986; 4: 204–208
   PubMed Web of Science ®Google Scholar
• Holliday R. DNA Methylation: Molecular Biology and Biological Significance. Birkhauser Verlag, Basel 1992
   Google Scholar
• Clark S. J., Harrison J., Frommer M. CpNpG methylation in mammalian cells. Nature Genet. 1995; 10: 20–27
   PubMed Web of Science ®Google Scholar
• Riggs A. D., Jones P. A. 5‐methylcytosine. gene regulation and cancer. Adv. Cancer Rex 1983; 40: 1–30
   PubMed Web of Science ®Google Scholar
• Bird A., Taggart M., Frommer M., Miller O. J., McLeod D. A fraction of the mouse genorrie that is derived from islands of non‐methylated CpG‐rich DNA. Cell 1985; 40: 91–99
   PubMed Web of Science ®Google Scholar
• Naveh‐Many T., Cedar H. Active gene sequences are undermethylated. Proc. Natl. Acad. Sci. (USA). 1981; 78: 4246–4250
   PubMed Web of Science ®Google Scholar
• Gardiner‐Garden M., Frommer M. CpG islands in vertebrate genomes. J. Mol. Bid. 1987; 196: 261–282
   PubMed Web of Science ®Google Scholar
• Duncan B. K., Miller J. H. Mutagenic deamination of cytosine residues in DNA. Nature 1980; 287: 560–561
   PubMed Web of Science ®Google Scholar
• Bestor T. H., Ingram V. M. Two methyltransferases from murk erythroleukemia cells: purification, sequence specificity and mode of action with DNA. Proc. Natl. Acad. Sci. (USA) 1983; 80: 5559–5563
   PubMed Web of Science ®Google Scholar
• Yen R. W. C., Vertino P. M., Nelkin B. D., Yu J. J., El‐Deiry W., Cumaraswamy A., Lennon G. G., Trask B. J., Celano P., Baylin S. J. Isolation and characterisation of the cDNA encoding human DNA methyltransferase. Nucl. Acids Res. 1992; 20: 2287–2291
   PubMed Web of Science ®Google Scholar
• Bestor T., Laudano A., Mattaliano R., Ingram V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. J. Mol. Bid. 1988; 203: 971–983
   PubMed Web of Science ®Google Scholar
• Jost J. P. Nuclear extracts of chicken embryos promote an active demethylation of DNA by excision repair of 5‐methyldeoxycytidine. Proc. Natl. Acad. Sci. (USA). 1993; 90: 46844688
   Web of Science ®Google Scholar
• Paroush Z., Keshet I., Yisraeli J., Cedar H. Dynamics of demethylation and activation of the α‐actin gene in myoblasts. Cell 1990; 63: 1229–1237
   PubMed Web of Science ®Google Scholar
• Holliday R. The inheritance of epigenetic defects. Science 1987; 238: 163–170
   PubMed Web of Science ®Google Scholar
• Keshet I., Yisraeli J., Cedar H. Effect of regional DNA methylation on gene expression. Proc. Natl. Acad. Sci. (USA). 1985; 82: 2560–2564
   PubMed Web of Science ®Google Scholar
• Li E., Beard C., Jaenisch R. Role for DNA methylation in genomic imprinting. Nature 1993; 366: 362–365
   PubMed Web of Science ®Google Scholar
• Monk M., Boabelik M., Lehnert S. Temporal and regional changes in DNA methylation in the embryonic, extraembryonic and germ cell lineages during mouse embryo development. Development 1987; 99: 371–382
   PubMed Web of Science ®Google Scholar
• Meehan R. R., Lewis J. D., McKay S., Kleiner E. L., Bird A. Identification of a mammalian protein that binds specifically to DNA containing methylated CpGs. Cell 1989; 58: 499–507
   PubMed Web of Science ®Google Scholar
• Ehrlich M., Ehrlich K. C. DNA Methylation. Molecular Biology and Biological Significance. Birkhauser Verlag, Base 1993
   Google Scholar
• Taylor S. M., Jones P. A. Multiple new phenotypes induced in 10T1/2 3T3 cells treated with 5‐azacytidine. Cell 1979; 17: 771–179
   PubMed Web of Science ®Google Scholar
• Baylin S. B., Makos M., Wu J., Yen R. W. C., de Bustros A., Vertino P., Nelkin B. D. Abnormal patterns of DNA methylation in human neoplasia: potential consequences for tumor progression. Cancer Cells 1991; 3: 383–390
   PubMed Web of Science ®Google Scholar
• De Simone J., Heller P., Hall L., Zwiers D. 5‐azacytidine stimulates fetal hemoglobin synthesis in anemic baboons. Proc. Natl. Acad. Sci. (USA) 1982; 79: 4428–4431
   PubMed Web of Science ®Google Scholar
• Charache S., Dover G., Smith K., Talhot C. C., Moyer M., Boyer S. Treatment of sickle cell anemia with 5‐azacytidine results in increased fetal haemoglobin products and is associated with non‐random hypomethylation of DNA around the γ‐α‐β‐globin gene complex. Proc. Natl. Acad. Sci. (USA). 1983; 80: 4842–4846
   PubMed Web of Science ®Google Scholar
• Gama‐Sosa M. A., Slagel V. A., Trewyn R. W., Oxenhandler R., Kuo K. C., Gehrke C. W., Ehrlich M. The 5‐methylcytosine content of DNA from human tumors. Nucl. Acids Rex 1983; 11: 6883–6894
   PubMed Web of Science ®Google Scholar
• Laird P. W., Jackson‐Grusby L., Fazell A., Dickinson S. L., Jung W. E., Li E., Weinberg R. A., Jaenisch R. Suppression of intestinal neoplasia by DNA hypomethylation. Cell 1995; 81: 197–205
   PubMed Web of Science ®Google Scholar
• El‐Deiry W. S., Nelkin B. D., Celano P., Yen R. ‐W. C., Falco J. P., Hamilton S. R., Baylin S. B. High expression of the methyltransferase gene characterises human neoplastic cells and progression stages of colon cancer. Proc. Natl. Acad. Sci. (USA). 1991; 88: 3470–3474
   PubMed Web of Science ®Google Scholar
• MacLeod A. R., Szyf M. Expression of antisense to DNA methyltransferase mRNA induces DNA demethylation and inhibits tumorigenesis. J. Bid. Chern. 1995; 270: 80377–8043
   Google Scholar
• Ohtani‐Fujita N., Fujita T., Aoike A., Osifchin N. E., Robbins P. D., Sakai T. CpG methylation inactivates the promoter activity of the human retinoblastoma tumor suppressor gene. Oncogene. 1993; 8: 1063–1067
   PubMed Web of Science ®Google Scholar
• Herman J. G., Latif F., Weng Y., Lerman M. I., Zbar B., Liu S., Samid D., Duan D. S. R., Gnarra J. R., Linehan W. M., Baylin S. B. Silencing of the VHL tumor‐suppressor gene by DNA methylation in renal carcinoma. Proc. Natl. Acad. Sci. USA 1994; 91: 9700–9704
   PubMed Web of Science ®Google Scholar
• Merlo A., Herman J. G., Mao L., Lee D. J., Gabrielson E., Burger P. C., Baylin S. B., Sidransky D. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/cDKN2/MTS1 in human cancers. Nature Med. 1995; 1: 686–692
   PubMed Web of Science ®Google Scholar
• Braun T., Bober E., Buschhausen‐Denker G., Kotz S., Grzeschik K. H., Arnold H. H. Differential expression of myogenic determination genes in muscle cells: possible autoactivation by the M>;f gene products. EMBO J. 1989; 8: 3617–3625
   PubMed Web of Science ®Google Scholar
• Kay P. H., Taylor J., Kees U. R., Baker D. L., Spagnolo D. Myf‐3 hypermethylation in malignant lymphoproliferative disorders. Br. J. Cancer. 1995; 62: 797–799
   Web of Science ®Google Scholar
• Jones P. A., Wolkowicz M. J., Hanington M. A., Gonzalez F. Methylation and expression of the Myo‐D1 determination gene. Philos. Trans, R. Soc. London 1990; 326: 277–284
   PubMed Web of Science ®Google Scholar
• Davis R. L., Weintraub H., Lassar A. B. Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell 1987; 51: 987–1000
   PubMed Web of Science ®Google Scholar
• Jones P. A., Wolkowicz M. J., Rideout W. M., III, Gonzales F. A., Marziasz G. A., Coetzee G. A., Tapscott S. J. De novo methylation of the MyoDl CpG island during the establishment of immortal cell lines. Proc. Natl. Acad. Sci. (USA) 1990; 87: 6117–21
   PubMed Web of Science ®Google Scholar
• Song K., Yaoqi W., Sassoon D. Expression of Hox‐7.1 in myoblasts inhibits terminal differentiation and induces cell transformation. Nature 1992; 360: 477–481
   PubMed Web of Science ®Google Scholar
• Sorrentino V. R., Peperkok R., Davis R. L., Ansorge W., Philipson L. Cell proliferation inhibited by MyoD. Nature 1990; 345: 813–815
   PubMed Web of Science ®Google Scholar
• Crescenzi M., Fleming T. P., Lassar A. B., Weintraub H., Aaronson S. A. MyoD induces growth arrest independent of differentiation in normal and transformed cells. Proc. Natl. Acad. Sci. (USA) 1990; 87: 8442–8446
   PubMed Web of Science ®Google Scholar
• Halevy O., Novitch B. G., Spicer D. B., Skapek S. X., Rhee J., Hannon G. J., Berach D., Lassar A. B. Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 1995; 267: 1018–1021
   PubMed Web of Science ®Google Scholar
• Tapscott S. J., Davis R. L., Thayer M. I., Cheng P. ‐F., Weintraub H., Lassar A. B. Myo‐DI: a nuclear phosphoprotein requiring a Myc homology region to convert fibroblasts to myoblasts. Science 1988; 242: 405–411
   PubMed Web of Science ®Google Scholar
• Beuche M., Senni M. I., Grossi A. M., Zappelli F., Polimeni M., Arnold H. H., Cossu G., Molinaro M. TPA‐induced differentiation of human rhabdomyosarcoma cells: expression of the myogenic regulatory factors. Exp. Cell Rex 1993; 208: 205–217
   Google Scholar
• Stoye J. P., Moroni C., Coffin J. M. Virological events leading to spontaneous AKR thymomas. J. Virol. 1991; 65: 1273–1285
   PubMed Web of Science ®Google Scholar
• Kay P. H., Jacobsen P. F., Taylor J., Spagnolo D. The significance of DNA methylation in Cancer. Adv. Anat. Path. 1995; 2: 353–361
   Google Scholar
• Adams B., Dorfler P., Aguzzi A., Koznik Z., Urbanck P., Maurer‐Fogy I., Busslinger M. Pax‐5 encodes the transcription factor BSAP and is expressed in B lymphocytes, the developing CNS, and adult testis. Genes Dev. 1992; 6: 1589–1607
   PubMed Web of Science ®Google Scholar
• Maulbecker C. C., Gruss P. The oncogenic potential of Pax genes. EMBO J. 1993; 12: 2361–2367
   PubMed Web of Science ®Google Scholar
• Tsukamoto K., Nakamura Y., Niikawa N. Isolation of two isoforms of the PAX3 transcripts and their tissue specific abberative expression in human adult tissues. Genet. 1994; 93: 270–274
   Web of Science ®Google Scholar
• Schafer B. W., Czerny T., Bernasconi M., Genini M., Busslinger M. Molecular cloning and characterisation of a human PAX‐7 cDNA expressed in normal and neoplastic myocytes. Nucl. Acids Res. 1994; 22: 4574–4582
   PubMed Web of Science ®Google Scholar
• Goulding M., Chalepakis G., Deutsch V., Erselius J. R., Gnss P. Pax‐3, a novel murine DNA binding protein expressed during early neurogenesis. EMBO J. 1991; 10: 1135–1147
   PubMed Web of Science ®Google Scholar
• Goulding M., Paquette A. Neural Tube Defects. Ciba Foundation Symposium 181, Wiley, Chichester 1994; 103–117
   Google Scholar
• Kioussi C., Gross M. K., Gruss P. Pax3: a paired domain gene as a regulator in PNS myelination. Neuron. 1995; 15: 553–562
   PubMed Web of Science ®Google Scholar
• Chalepakis G., Jones F. S., Edelman G. M., Gnss P. Pax‐3 contains domains for transcription activation and transcription inhibition. Proc. Natl. Acad. Sci. USA 1994; 91: 12745–12749
   PubMed Web of Science ®Google Scholar
• Stuart E. T., Kioussi C., Gruss P. Mammalian PAX genes. Annu. Rev. Genet. 1993; 27: 219–236
   Google Scholar
• Epstein D. J., Vekemans M., Gros P. Splotch (Sp2H), a mutation affecting development of the mouse neural tube, shows a deletion within a paired homeodomain of Pax‐3. Cell 1991; 67: 767–774
   PubMed Web of Science ®Google Scholar
• Bober E., Franz T., Arnold H. H., Gnss P., Tremblay P. Pax‐3 is required for the development of limb muscles: a possible role for the migration of dermomyotomal muscle progenitor cells. Development 1994; 120: 603–612
   PubMed Web of Science ®Google Scholar
• Jostes B., Walther C., Gruss P. The murine paired box gene, Pax7, is expressed specifically during the development of the nervous and muscular system. Mech. Dev. 1991; 33: 27–38
   Web of Science ®Google Scholar
• Yaffe D., Saxel D. Serial passaging and differentiation of myogenic cells isolated from dystrophic mouse muscle. Nature 1977; 270: 725–727
   PubMed Web of Science ®Google Scholar
• Spagnolo D. V., Taylor J., Carrello S., Saueracker E., Kay P. H. Southern blot analysis of lymphoproliferative disorders: use and limitations in routine surgical pathology. Pathology 1994; 26: 268–275
   PubMed Web of Science ®Google Scholar